Orion OYJ (OTCMKTS:ORINY) Sets New 52-Week High – Should You Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $46.00 and last traded at $46.00, with a volume of 108 shares traded. The stock had previously closed at $45.8150.

Orion OYJ Stock Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The business has a fifty day simple moving average of $42.86 and a 200 day simple moving average of $40.13. The stock has a market cap of $12.98 billion, a price-to-earnings ratio of 18.93 and a beta of 0.08.

Orion OYJ (OTCMKTS:ORINY) last issued its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The business had revenue of $606.38 million for the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.

About Orion OYJ

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.